Benefits of ethyl gallate versus norepinephrine in the treatment of cardiovascular collapse in Pseudomonas aeruginosa septic shock in dogs

Critical Care Medicine

Volumn 40, Issue 2, 2012, Pages 560-572

  Gotes, Jose ^a   Kasian, Krika ^b   Jacobs, Hans ^b   Cheng, Zhao Qin ^b   Mink, Steven N ^b,c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY OF MANITOBA   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

antioxidants; hydrogen peroxide signaling; infection; myocardial depression; vasodilation; vasopressors

Indexed keywords

ANTIOXIDANT; CREATININE; GALLIC ACID ETHYL ESTER; NORADRENALIN; PLACEBO; TROPONIN T; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOG; DRUG DOSE TITRATION; DRUG MECHANISM; HEART MUSCLE INJURY; HEART RATE; HEART STROKE VOLUME; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SHOCK; SYSTEMIC VASCULAR RESISTANCE; URINE VOLUME;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GALLIC ACID; NOREPINEPHRINE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOM ALLOCATION; RISK ASSESSMENT; SHOCK, CARDIOGENIC; SHOCK, SEPTIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84856133301     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318232d8a6     Document Type: Article

References (38)

1. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
2. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
3. Patel GP, Grahe JS, Sperry M, et al: Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 2010; 33:375-380
4. De Backer D, Biston P, Devriendt J, et al: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779-789
5. Russell JA Walley KR, Singer J, et al: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
6. Mink SN, Jacobs H, Gotes J, et al: Ethyl gallate, a scavenger of hydrogen peroxide that inhibits lysozyme-induced hydrogen peroxide signaling in vitro, reverses hypotension in canine septic shock. J Appl Physiol 2011; 110:359-374
7. Zhang Z, Liao L, Moore J, et al: Antioxidant phenolic compounds from walnut kernels. Food Chemistry 2009; 113:160-165
8. Monagas M, Suarez R, Gomez-Cordoves C, et al: Simultaneous determination of nonanthocyanin phenolic compounds in red wines by HPLC-DAD/ESI-MS. American Journal of Enology and Viticulture 2005; 56:139-147
9. Mink SN, Jacobs H, Bose D, et al: Lysozyme: A mediator of myocardial depression and adrenergic dysfunction in septic shock in dogs. J Mol Cell Cardiol 2003; 35:265-275
10. Mink SN, Jacobs H, Cheng ZQ, et al: Lysozyme, a mediator of sepsis that intrinsically generates hydrogen peroxide to cause cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 2009; 297:H930-H948
11. Mink SN, Kasian K, Santos Martinez LE, et al: Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation. Am J Physiol Heart Circ Physiol 2008; 294: H1724-H1735
12. Fleming A: On a remarkable bacteriolytic element found in tissue and secretions. Proceedings of the Royal Society London B 1922; 93:306-307
13. Cai H: Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovasc Res 2005; 68: 26-36
14. Wentworth AD, Jones LH, Wentworth P Jr, et al: Antibodies have the intrinsic capacity to destroy antigens. Proc Natl Acad Sci U S A 2000; 97:10930-10935
15. Wentworth P Jr, Jones LH, Wentworth AD, et al: Antibody catalysis of the oxidation of water. Science 2001; 293:1806-1811
16. Gilman AG: G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 1987; 56:615-649
17. Danner RL, Natanson C, Elin RJ, et al: Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest 1990; 98:1480-1487
18. National Institutes of Health: Guide for the Care and Use of Laboratory Animals. Bethesda, MD, National Institutes of Health, NIH Publication No 85-23, 1996
19. Gomez A, Wang R, Unruh H, et al: Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73:671-685
20. Mink SN, Jha P, Wang R, et al: Effect of continuous arteriovenous hemofiltration combined with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 1995; 83:178-190
21. Røsjø H, Varpula M, Hagve TA, et al: Circulating high sensitivity troponin T in severe sepsis and septic shock: Distribution, associated factors, and relation to outcome. Intensive Care Med 2011; 37:77-85
22. Kahn DS, Rona G, Chappel CI: Isoproterenolinduced cardiac necrosis. Ann N Y Acad Sci 1969; 156:285-293
23. Goldspink DF, Burniston JG, Ellison GM, et al: Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: The same or separate death pathwayš Exp Physiol 2004; 89:407-416
24. Burniston JG, Ng Y, Clark WA, et al: Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 2002; 93: 1824-1932
25. Hsieh TJ, Liu TZ, Chia YC, et al: Protective effect of methyl gallate from Toona sinensis (Meliaceae) against hydrogen peroxideinduced oxidative stress and DNA damage in MDCK cells. Food Chem Toxicol 2004; 42: 843-850
26. Dossetor JB: Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia. Ann Intern Med 1966; 65: 1287-1299
27. Pereira DM, Valentão P, Pereira JA, et al: Phenolics: From chemistry to biology. Molecules 2009; 14:2202-2211
28. Jayaraman P, Sakharkar MK, Lim CS, et al: Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int J Biol Sci 2010; 6:556-568
29. Saavedra MJ, Borges A, Dias C, et al: Antimicrobial activity of phenolics and glucosinolate hydrolysis products and their synergy with streptomycin against pathogenic bacteria. Med Chem 2010; 6:174-183
30. Rodríguez Vaquero MJ, Aredes Fernández PA, Manca de Nadra MC, et al: Phenolic compound combinations on Escherichia coli viability in a meat system. J Agric Food Chem 2010; 58:6048-6052
31. Jayaraman P, Sakharkar KR, Sing LC, et al: Insights into antifolate activity of phytochemicals against Pseudomonas aeruginosa. J Drug Target 2011; 19:179-188
32. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005; 365:63-78
33. Natanson C, Fink MP, Ballantyne HK, et al: Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 1986; 78:259-270
34. Grover R, Zaccardelli D, Colice G, et al: An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-Larginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 1999; 27:913-922
35. Gao S, Zhan Q, Li J, et al: LC-MS/MS method for the simultaneous determination of ethyl gallate and its major metabolite in rat plasma. Biomed Chromatogr 2010; 24: 472-478
36. Rand-Meir T, Dahlquist FW, Raftery MA: Use of synthetic substrates to study binding and catalysis by lysozyme. Biochemistry 1969; 8:4206-4214
37. Shugar D: The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme. Biochim Biophys Acta 1952; 8:302-309
38. Biesalski HK, McGregor GP: Antioxidant therapy in critical care-is the microcirculation the primary target? Crit Care Med 2007; 35:S577-S583